Suppressor of cytokine signaling (SOCS)-5 is a potential negative regulator of epidermal growth factor signaling

被引:76
作者
Nicholson, SE [1 ]
Metcalf, D
Sprigg, NS
Columbus, R
Walker, F
Silva, A
Cary, D
Willson, TA
Zhang, JG
Hilton, DJ
Alexander, WS
Nicola, NA
机构
[1] Walter & Eliza Hall Inst Med Res, Cooperat Res Ctr Cellular Growth Factors, Parkville, Vic 3052, Australia
[2] Ludwig Inst Canc Res, Melbourne Tumour Biol Branch, Parkville, Vic 3052, Australia
关键词
D O I
10.1073/pnas.0409675102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The suppressors of cytokine signaling (SOCS) proteins are a family of SH2 domain-containing intracellular inhibitors of cytokine signal transduction that act by several different mechanisms. Recent evidence suggests that the action of the SOCS proteins may extend beyond the cytokine receptors to signaling initiated by members of the tyrosine kinase receptor family. In this study, the ability of SOCS-5 to negatively regulate signaling cascades downstream of the epidermal growth factor receptor (EGF-R) has been examined by using an EGF-responsive cell line engineered to constitutively express the EGF-R and SOCS-5 or SOCS-5 mutants. SOCS-5 associated with the EGF-R complex in an EGF-independent manner, and the mitogenic response to EGF of all SOCS-5-expressing cell lines was dramatically inhibited when compared with control cell lines. Furthermore, this effect was abrogated after deletion of the SOCS-5 SOCS box. This result suggests that the inhibition of signaling occurs through enhanced proteasomal degradation of the EGF-R through SOCS box recruitment of E3 ubiquitin ligase activity.
引用
收藏
页码:2328 / 2333
页数:6
相关论文
共 41 条
[1]   SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine [J].
Alexander, WS ;
Starr, R ;
Fenner, JE ;
Scott, GL ;
Handman, E ;
Sprigg, NS ;
Corbin, JE ;
Cornish, AL ;
Darwiche, R ;
Owczarek, CM ;
Kay, TWH ;
Nicola, NA ;
Hertzog, PJ ;
Metcalf, D ;
Hilton, DJ .
CELL, 1999, 98 (05) :597-608
[2]   SHP-2 regulates SOCS-1-mediated Janus kinase-2 ubiquitination/degradation downstream of the prolactin receptor [J].
Ali, S ;
Nouhi, Z ;
Chughtai, N ;
Ali, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (52) :52021-52031
[3]   SOCS5 is expressed in primary B and T lymphoid cells but is dispensable for lymphocyte production and function [J].
Brender, C ;
Columbus, R ;
Metcalf, D ;
Handman, E ;
Starr, R ;
Huntington, N ;
Tarlinton, D ;
Odum, N ;
Nicholson, SE ;
Nicola, NA ;
Hilton, DJ ;
Alexander, WS .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (13) :6094-6103
[4]  
BURGESS AW, 1983, EMBO J, V2, P2065, DOI 10.1002/j.1460-2075.1983.tb01701.x
[5]   Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras [J].
Cacalano, NA ;
Sanden, D ;
Johnston, JA .
NATURE CELL BIOLOGY, 2001, 3 (05) :460-465
[6]   SOCS36E, a novel Drosophila SOCS protein, suppresses JAK/STAT and EGF-R signalling in the imaginal wing disc [J].
Callus, BA ;
Mathey-Prevot, B .
ONCOGENE, 2002, 21 (31) :4812-4821
[7]   SOCS3 negatively regulates IL-6 signaling in vivo [J].
Croker, BA ;
Krebs, DL ;
Zhang, JG ;
Wormald, S ;
Willson, TA ;
Stanley, EG ;
Robb, L ;
Greenhalgh, CJ ;
Förster, I ;
Clausen, BE ;
Nicola, NA ;
Metcalf, D ;
Hilton, DJ ;
Roberts, AW ;
Alexander, WS .
NATURE IMMUNOLOGY, 2003, 4 (06) :540-545
[8]   Suppressor of cytokine signaling-1 inhibits VAV function through protein degradation [J].
De Sepulveda, P ;
Ilangumaran, S ;
Rottapel, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (19) :14005-14008
[9]  
De Sepulveda P, 1999, EMBO J, V18, P904
[10]   Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor [J].
Dey, BR ;
Spence, SL ;
Nissley, P ;
Furlanetto, RW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (37) :24095-24101